1 | barriers | 3,876 |
2 | alternatives | 1,904 |
3 | contraindications | 1,104 |
4 | obstacles | 489 |
5 | facilitators | 406 |
6 | threats | 337 |
7 | urges | 174 |
8 | obligations | 94 |
9 | objections | 91 |
10 | motivators | 63 |
11 | impediments | 61 |
12 | contra-indications | 55 |
13 | gatekeepers | 51 |
14 | deterrents | 23 |
15 | disincentives | 16 |
16 | deference | 13 |
17 | roadblocks | 11 |
18 | superstitions | 11 |
19 | norfentanyl | 9 |
20 | quackery | 9 |
21 | exemptions | 7 |
22 | self-competence | 7 |
23 | add-ons | 6 |
24 | preventatives | 5 |
25 | zuoyuezi | 5 |
26 | cys306 | 4 |
27 | eagerness | 4 |
28 | gaits | 4 |
29 | subpoenas | 4 |
30 | barriers/enablers | 3 |
31 | expositions | 3 |
32 | loosens | 3 |
33 | oncomirs | 3 |
34 | tracer-rav2 | 3 |
35 | uncommitted | 3 |
36 | 2.526 | 2 |
37 | 5'-monophosphates | 2 |
38 | airblasts | 2 |
39 | benefits/barriers | 2 |
40 | br+nut | 2 |
41 | clinician/therapist | 2 |
42 | detours | 2 |
43 | e-mailing | 2 |
44 | intrabodies | 2 |
45 | invulnerable | 2 |
46 | menaces | 2 |
47 | neo-epitopes | 2 |
48 | skvrs | 2 |
49 | supportively | 2 |
50 | talaga | 2 |
51 | wox12 | 2 |
52 | 2-epimerization | 1 |
53 | abt-737-resistance | 1 |
54 | autonomics | 1 |
55 | burdensomeness-belief | 1 |
56 | cardio-myogenesis | 1 |
57 | cbfv-reduction | 1 |
58 | cisplatin-resistance | 1 |
59 | dachangjing | 1 |
60 | exposure/contamination | 1 |
61 | fe3+-heme | 1 |
62 | fundamentalness | 1 |
63 | institutional/organizational | 1 |
64 | overreferral | 1 |
65 | primer-length | 1 |
66 | self-justifications | 1 |
67 | silica-matrix | 1 |
68 | studies.low- | 1 |
69 | toxoplasmagondii | 1 |
70 | transcriptional-modulators | 1 |
71 | wrongdoer | 1 |
1 | 2-epimerization | 1 |
2 | 2.526 | 2 |
3 | 5'-monophosphates | 2 |
4 | abt-737-resistance | 1 |
5 | add-ons | 6 |
6 | airblasts | 2 |
7 | alternatives | 1,904 |
8 | autonomics | 1 |
9 | barriers | 3,876 |
10 | barriers/enablers | 3 |
11 | benefits/barriers | 2 |
12 | br+nut | 2 |
13 | burdensomeness-belief | 1 |
14 | cardio-myogenesis | 1 |
15 | cbfv-reduction | 1 |
16 | cisplatin-resistance | 1 |
17 | clinician/therapist | 2 |
18 | contra-indications | 55 |
19 | contraindications | 1,104 |
20 | cys306 | 4 |
21 | dachangjing | 1 |
22 | deference | 13 |
23 | deterrents | 23 |
24 | detours | 2 |
25 | disincentives | 16 |
26 | e-mailing | 2 |
27 | eagerness | 4 |
28 | exemptions | 7 |
29 | expositions | 3 |
30 | exposure/contamination | 1 |
31 | facilitators | 406 |
32 | fe3+-heme | 1 |
33 | fundamentalness | 1 |
34 | gaits | 4 |
35 | gatekeepers | 51 |
36 | impediments | 61 |
37 | institutional/organizational | 1 |
38 | intrabodies | 2 |
39 | invulnerable | 2 |
40 | loosens | 3 |
41 | menaces | 2 |
42 | motivators | 63 |
43 | neo-epitopes | 2 |
44 | norfentanyl | 9 |
45 | objections | 91 |
46 | obligations | 94 |
47 | obstacles | 489 |
48 | oncomirs | 3 |
49 | overreferral | 1 |
50 | preventatives | 5 |
51 | primer-length | 1 |
52 | quackery | 9 |
53 | roadblocks | 11 |
54 | self-competence | 7 |
55 | self-justifications | 1 |
56 | silica-matrix | 1 |
57 | skvrs | 2 |
58 | studies.low- | 1 |
59 | subpoenas | 4 |
60 | superstitions | 11 |
61 | supportively | 2 |
62 | talaga | 2 |
63 | threats | 337 |
64 | toxoplasmagondii | 1 |
65 | tracer-rav2 | 3 |
66 | transcriptional-modulators | 1 |
67 | uncommitted | 3 |
68 | urges | 174 |
69 | wox12 | 2 |
70 | wrongdoer | 1 |
71 | zuoyuezi | 5 |
1 | studies.low- | 1 |
2 | wox12 | 2 |
3 | tracer-rav2 | 3 |
4 | cys306 | 4 |
5 | 2.526 | 2 |
6 | talaga | 2 |
7 | uncommitted | 3 |
8 | abt-737-resistance | 1 |
9 | cisplatin-resistance | 1 |
10 | deference | 13 |
11 | self-competence | 7 |
12 | invulnerable | 2 |
13 | fe3+-heme | 1 |
14 | burdensomeness-belief | 1 |
15 | dachangjing | 1 |
16 | e-mailing | 2 |
17 | primer-length | 1 |
18 | toxoplasmagondii | 1 |
19 | zuoyuezi | 5 |
20 | institutional/organizational | 1 |
21 | overreferral | 1 |
22 | norfentanyl | 9 |
23 | exposure/contamination | 1 |
24 | 2-epimerization | 1 |
25 | cbfv-reduction | 1 |
26 | wrongdoer | 1 |
27 | subpoenas | 4 |
28 | autonomics | 1 |
29 | menaces | 2 |
30 | urges | 174 |
31 | intrabodies | 2 |
32 | obstacles | 489 |
33 | neo-epitopes | 2 |
34 | 5'-monophosphates | 2 |
35 | alternatives | 1,904 |
36 | preventatives | 5 |
37 | disincentives | 16 |
38 | cardio-myogenesis | 1 |
39 | roadblocks | 11 |
40 | loosens | 3 |
41 | add-ons | 6 |
42 | contra-indications | 55 |
43 | contraindications | 1,104 |
44 | self-justifications | 1 |
45 | obligations | 94 |
46 | objections | 91 |
47 | expositions | 3 |
48 | superstitions | 11 |
49 | exemptions | 7 |
50 | barriers | 3,876 |
51 | benefits/barriers | 2 |
52 | barriers/enablers | 3 |
53 | gatekeepers | 51 |
54 | oncomirs | 3 |
55 | transcriptional-modulators | 1 |
56 | facilitators | 406 |
57 | motivators | 63 |
58 | detours | 2 |
59 | skvrs | 2 |
60 | fundamentalness | 1 |
61 | eagerness | 4 |
62 | threats | 337 |
63 | gaits | 4 |
64 | impediments | 61 |
65 | deterrents | 23 |
66 | airblasts | 2 |
67 | clinician/therapist | 2 |
68 | br+nut | 2 |
69 | silica-matrix | 1 |
70 | supportively | 2 |
71 | quackery | 9 |